Evidence map›Paper›PMID 33673061›Full record

ArticleCells2021

Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified

Jian Du, Christian Agatemor, Christopher T Saeui, Rahul Bhattacharya, Xiaofeng Jia, Kevin J Yarema

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Applications of Metabolic Glycoengineering.Frontiers in cell and developmental biology · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jian DuDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0001-7154-8987
Christian AgatemorDepartment of Biomedical Engineering, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Christopher T SaeuiDepartment of Biomedical Engineering, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Rahul BhattacharyaDepartment of Biomedical Engineering, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
Xiaofeng JiaDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0003-1445-8525
Kevin J YaremaDepartment of Biomedical Engineering, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

Funding

Stem Cell Surface Modification to Promote Nerve RegenerationR01NS117102 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI Xiaofeng Jia · 2021 to 2026
$2.0M
Brain Recovery after Cardiac Arrest with Metabolic Glycoengineered Stem CellsR01NS110387 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI JIA, XIAOFENG · 2018 to 2022
$1.7M
Engineering a Carbohydrate-Biomaterial Interface for Control of Wnt Signaling andR01EB005692 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI YAREMA, KEVIN J · 2007 to 2010
$1.4M
NIBIB NIH HHS R01 EB005692NINDS NIH HHS R01 NS110387NINDS NIH HHS R01 NS117102
6 · The paper itself

Abstract

This report describes novel thiol-modified

Indexed as

AdipocytesCell DifferentiationGlycoconjugatesHexosaminesHumansN-Acetylneuraminic AcidStem CellsSulfhydryl CompoundsGlycoconjugatesHexosaminesN-acetylmannosamineN-Acetylneuraminic AcidSulfhydryl Compoundsadipose stem cell glycoengineeringmetabolic glycoengineeringN-acetylmannosamine (ManNAc) analogsneural stem cell glycoengineeringstem cell differentiation

Identifiers

PMID33673061
PMCPMC7918483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.